Mark Coleman - Director at Axsome Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
AXSM on Nasdaq
All Insider Reports
All Insider Reports

Mark Coleman - trading volume in the past year for Axsome Therapeutics, Inc.

Holdings reported by Mark Coleman for Axsome Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 14.6K $1.1M $75.14 May 29, 2024 Direct
Stock Option (Right to Buy) 5.8K Jun 7, 2024 Direct Common Stock

Transactions reported by Mark Coleman for Axsome Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.